Podcast

Joseph Solomkin, MD, on the Results From the IGNITE4 Trial

10/18/2016

 

In this podcast, Joseph Solomkin, MD, answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients.

Additional Reading:

  • Solomkin JS, Gardovskis J, Lawrence K, et al. IGNITE4: results of a phase 3, randomized, multicenter, prospective trial of eravacycline vs meropenem in the treatment of complicated intraabdominal infections. Clin Infect Dis. 2019;69(6):921-929. https://doi.org/10.1093/cid/ciy1029. 

 

Joseph Solomkin, MD, is a Professor of Surgery Emeritus at the University of Cincinnati in Ohio. He is also a consultant for Tetraphase, the pharmaceutical company that produces eravacycline.

Related Content

Infectious Diseases
Infectious Diseases
Valerie Delpech, MBBS, MPH, on the Trends of HIV Infection in the United Kingdom
06/05/2020
She speaks about the UK HIV epidemic and the programs that were implemented that helped reduce the number of HIV infections in the region.
06/05/2020
Lipid & Metabolic
Lipid & Metabolic
Paul Jellinger, MD, MACE, on the Role of CAC Score
12/31/2020
In part 5 of our series on lipid management, Paul Jellinger, MD, MACE, highlights the importance of coronary artery calcium score as a risk factor for ASCVD and its role in diagnosis and treatment of...
12/31/2020
HIV Management
HIV Management
Bill Kapogiannis, MD, on Disparities Among Youth With HIV in the Care Continuum
03/27/2020
In this podcast, Bill Kapogiannis, MD, discusses the multi-Federal agency SMILE Collaborative (Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of HIV-infected youth),...
03/27/2020
asthma
asthma
IL-6 as a Biomarker for Asthma Exacerbations
04/15/2022
In this podcast, Michael Peters, MD, talks about his team's cross-sectional analysis on the use of blood eosinophils and IL-6 as predictive biomarkers of the exacerbation-prone asthma phenotype over 3...
04/15/2022
Infectious Diseases
Infectious Diseases
Shane Crotty, PhD, on the Tfh Pathway
12/09/2018
Shane Crotty, PhD, from the La Jolla Institute for Immunology, talks about his discovery of the Tfh pathway and how it has affected the development of vaccines.
12/09/2018